nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR4—adrenal cortex—adrenal gland cancer	0.144	0.209	CbGeAlD
Cinitapride—HTR4—pituitary gland—adrenal gland cancer	0.116	0.169	CbGeAlD
Cinitapride—HTR2A—sympathetic nervous system—adrenal gland cancer	0.108	0.157	CbGeAlD
Cinitapride—HTR4—adrenal gland—adrenal gland cancer	0.104	0.151	CbGeAlD
Cinitapride—HTR2A—vein—adrenal gland cancer	0.101	0.147	CbGeAlD
Cinitapride—HTR2A—urine—adrenal gland cancer	0.0592	0.086	CbGeAlD
Cinitapride—HTR4—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—adrenal gland cancer	0.038	0.122	CbGpPWpGaD
Cinitapride—HTR4—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—adrenal gland cancer	0.0253	0.0812	CbGpPWpGaD
Cinitapride—HTR1A—adrenal gland—adrenal gland cancer	0.019	0.0276	CbGeAlD
Cinitapride—HTR4—G alpha (s) signalling events—TSHR—adrenal gland cancer	0.0146	0.0468	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.013	0.0418	CbGpPWpGaD
Cinitapride—HTR2A—gonad—adrenal gland cancer	0.013	0.0189	CbGeAlD
Cinitapride—HTR2A—pituitary gland—adrenal gland cancer	0.0127	0.0184	CbGeAlD
Cinitapride—HTR2A—adrenal gland—adrenal gland cancer	0.0113	0.0164	CbGeAlD
Cinitapride—HTR4—GPCR ligand binding—GNRHR—adrenal gland cancer	0.0099	0.0318	CbGpPWpGaD
Cinitapride—HTR2A—GPCRs, Other—GNRHR—adrenal gland cancer	0.0096	0.0309	CbGpPWpGaD
Cinitapride—HTR4—G alpha (s) signalling events—GNAS—adrenal gland cancer	0.00847	0.0272	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00779	0.025	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00694	0.0223	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00593	0.0191	CbGpPWpGaD
Cinitapride—HTR4—G alpha (s) signalling events—POMC—adrenal gland cancer	0.0057	0.0183	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00559	0.018	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.0054	0.0173	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—TSHR—adrenal gland cancer	0.00529	0.017	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00508	0.0163	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00483	0.0155	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00414	0.0133	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00357	0.0115	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00335	0.0108	CbGpPWpGaD
Cinitapride—HTR2A—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00323	0.0104	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00315	0.0101	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—GNAS—adrenal gland cancer	0.00307	0.00988	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00304	0.00978	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GNRHR—adrenal gland cancer	0.003	0.00965	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00299	0.0096	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00289	0.00929	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00279	0.00897	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00277	0.0089	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00272	0.00875	CbGpPWpGaD
Cinitapride—HTR4—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.00272	0.00874	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—TSHR—adrenal gland cancer	0.00271	0.00872	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—ZNRF3—adrenal gland cancer	0.00262	0.00843	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00248	0.00797	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00239	0.00768	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00221	0.0071	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00214	0.00688	CbGpPWpGaD
Cinitapride—HTR4—GPCR ligand binding—POMC—adrenal gland cancer	0.00207	0.00665	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00195	0.00626	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00191	0.00613	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00189	0.00607	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—CDC42—adrenal gland cancer	0.00182	0.00584	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GNRH1—adrenal gland cancer	0.0018	0.00578	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00178	0.00572	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—GNAS—adrenal gland cancer	0.00174	0.00558	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00168	0.00541	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—CDC42—adrenal gland cancer	0.00165	0.00531	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SPRY2—adrenal gland cancer	0.00164	0.00529	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00163	0.00524	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00162	0.0052	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00162	0.00519	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TSHR—adrenal gland cancer	0.0016	0.00515	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—GNAS—adrenal gland cancer	0.00158	0.00507	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00154	0.00494	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MEN1—adrenal gland cancer	0.00151	0.00484	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—TSHR—adrenal gland cancer	0.00145	0.00467	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GNRHR—adrenal gland cancer	0.0014	0.00449	CbGpPWpGaD
Cinitapride—HTR4—GPCR downstream signaling—POMC—adrenal gland cancer	0.00117	0.00376	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PRKACA—adrenal gland cancer	0.00115	0.0037	CbGpPWpGaD
Cinitapride—HTR1A—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00109	0.0035	CbGpPWpGaD
Cinitapride—HTR1A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00108	0.00346	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00107	0.00343	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—POMC—adrenal gland cancer	0.00106	0.00341	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000979	0.00315	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CDC42—adrenal gland cancer	0.000976	0.00314	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000969	0.00311	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000955	0.00307	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000951	0.00306	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF2—adrenal gland cancer	0.00094	0.00302	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—GNAS—adrenal gland cancer	0.000932	0.003	CbGpPWpGaD
Cinitapride—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000931	0.00299	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000921	0.00296	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IGF1R—adrenal gland cancer	0.000909	0.00292	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000888	0.00285	CbGpPWpGaD
Cinitapride—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000865	0.00278	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000863	0.00277	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	0.000845	0.00272	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000837	0.00269	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000835	0.00268	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000825	0.00265	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000821	0.00264	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TERT—adrenal gland cancer	0.000783	0.00252	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000767	0.00247	CbGpPWpGaD
Cinitapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000747	0.0024	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	0.000746	0.0024	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000721	0.00232	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—BAD—adrenal gland cancer	0.000681	0.00219	CbGpPWpGaD
Cinitapride—HTR1A—GPCR ligand binding—POMC—adrenal gland cancer	0.000659	0.00212	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—POMC—adrenal gland cancer	0.000628	0.00202	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—BRAF—adrenal gland cancer	0.00062	0.00199	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.00062	0.00199	CbGpPWpGaD
Cinitapride—HTR4—Signaling by GPCR—EGFR—adrenal gland cancer	0.000601	0.00193	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000579	0.00186	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000572	0.00184	CbGpPWpGaD
Cinitapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000571	0.00183	CbGpPWpGaD
Cinitapride—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	0.000569	0.00183	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000553	0.00178	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000535	0.00172	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000526	0.00169	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000523	0.00168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TSHR—adrenal gland cancer	0.00051	0.00164	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000502	0.00161	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	0.0005	0.00161	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	0.000494	0.00159	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MEN1—adrenal gland cancer	0.000479	0.00154	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000478	0.00154	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	0.000454	0.00146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	0.000452	0.00145	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000448	0.00144	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	0.000441	0.00142	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	0.000434	0.00139	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	0.000414	0.00133	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000372	0.0012	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000366	0.00118	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—adrenal gland cancer	0.000355	0.00114	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—POMC—adrenal gland cancer	0.000338	0.00109	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	0.000322	0.00103	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	0.000316	0.00102	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDC42—adrenal gland cancer	0.00031	0.000998	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF2—adrenal gland cancer	0.000299	0.000962	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—adrenal gland cancer	0.000298	0.000958	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—GNAS—adrenal gland cancer	0.000297	0.000953	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	0.000292	0.000939	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1R—adrenal gland cancer	0.000289	0.00093	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	0.000268	0.000862	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	0.000259	0.000831	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	0.000256	0.000824	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	0.00025	0.000803	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TERT—adrenal gland cancer	0.000249	0.000801	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BAD—adrenal gland cancer	0.000217	0.000696	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	0.000215	0.000692	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—POMC—adrenal gland cancer	0.0002	0.000642	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BRAF—adrenal gland cancer	0.000197	0.000634	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000191	0.000614	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	0.000187	0.000602	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	0.000173	0.000555	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	0.00017	0.000548	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	0.000165	0.000531	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000143	0.000458	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000123	0.000396	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—adrenal gland cancer	0.000113	0.000363	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	9.76e-05	0.000314	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—adrenal gland cancer	9.48e-05	0.000305	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	8.19e-05	0.000263	CbGpPWpGaD
